Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Epizyme
Biotech
ESMO: A peak at Pfizer's EZH2 inhibitor flashes hope for some
An early look at Pfizer's phase 1 EZH2 inhibitor teased a benefit for prostate cancer and follicular lymphoma but not small cell lung cancer patients.
Max Bayer
Sep 11, 2022 6:00am
Romanelli returns to Merck after brief CEO role—Chutes & Ladders
Apr 22, 2022 9:30am
Fierce Biotech launches layoff tracker—Chutes and Ladders
Apr 8, 2022 9:30am
Epizyme to trim workforce and pipeline in cost-cutting plan
Mar 1, 2022 1:14pm
GSK kills one of Barron's early darlings, axing Epizyme pact
Feb 9, 2022 6:14am
Merck's Vaxneuvance lead departs for Affinivax—Chutes & Ladders
Aug 13, 2021 9:30am